Accelerate Diagnostics Inc

1
NAS:AXDX (USA)   Ordinary Shares
$ 0.88 +0.0102 (+1.17%) 10:08 PM EST
At Loss
Market Cap:
$ 19.07M
Enterprise V:
$ 44.85M
Volume:
54.59K
Avg Vol (2M):
60.38K
Also Trade In:
Volume:
54.59K
At Loss
Avg Vol (2M):
60.38K

Business Description

Accelerate Diagnostics Inc
NAICS : 325413 SIC : 5047
ISIN : US00430H1023

Share Class Description:

AXDX: Ordinary Shares
Description
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
Name Current Vs Industry Vs History
Cash-To-Debt 0.34
Equity-to-Asset -0.63
Debt-to-Equity -1.97
Debt-to-EBITDA -0.79
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -34.35
Distress
Grey
Safe
Beneish M-Score -4.7
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 38.07
9-Day RSI 44.42
14-Day RSI 45.01
6-1 Month Momentum % -84.47
12-1 Month Momentum % -88.44

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.03
Quick Ratio 1.76
Cash Ratio 1.1
Days Inventory 172.22
Days Sales Outstanding 75.51
Days Payable 166.33

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -36.2
Shareholder Yield % 236.1